Suchergebnisse - "Podzamczer, Daniel"

PubPharm (8)

1

Pharmacokinetic analysis of nevirapine extended release 400 mg once daily vs nevirapine immediate release 200 mg twice daily formulation in treatment-naïve patients with HIV-1 infection

enthalten in: HIV clinical trials | 2017

von Yong, C. | Gathe, J. | Knecht, G. | +9

2

Atherogenic properties of LDL particles after switching from Truvada or Kivexa plus lopinavir/r to lamivudine plus lopinavir/r : OLE-MET substudy

enthalten in: HIV clinical trials | 2017

von Saumoy, M. | Tiraboschi, J. | Ordoñez-Llanos, J. | +6

3

Atherogenic properties of LDL particles after switching from Truvada or Kivexa plus lopinavir/r to lamivudine plus lopinavir/r: OLE-MET substudy

enthalten in: HIV clinical trials | 2017

von Saumoy, M. | Tiraboschi, J. | Ordoñez-Llanos, J. | +6

4

Liver toxicity of initial antiretroviral drug regimens including two nucleoside analogs plus one non-nucleoside analog or one ritonavir-boosted protease inhibitor in HIV/HCV-coinfected patients

enthalten in: HIV clinical trials | 2012

von Macías, J. | Neukam, K. | Mallolas, J. | +28

5

Efficacy and safety of switching from enfuvirtide to raltegravir in patients with virological suppression

enthalten in: HIV clinical trials | 2009

von Santos, J. | Llibre, J. | Ferrer, E. | +7

6

Efficacy and Safety of Switching from Enfuvirtide to Raltegravir in Patients with Virological Suppression

enthalten in: HIV clinical trials | 2009

von Santos, J. | Llibre, J. | Ferrer, E. | +7

7

High-dose lopinavir/ritonavir in highly treatment-experienced HIV-1 patients : efficacy, safety, and predictors of response

enthalten in: HIV clinical trials | 2007

von Podzamczer, D. | King, M. | Klein, C. | +7

8

High-Dose Lopinavir-Ritonavir in Highly Treatment-Experienced HIV-1 Patients: Efficacy, Safety, and Predictors of Response

enthalten in: HIV clinical trials | 2007

von Podzamczer, D. | King, M. | Klein, C. | +7

1
[1]